Ads
related to: inhalers for copd and asthma- Dosing Information
HCPs: See The Dosing Information Of
This Once-Daily Asthma Inhaler.
- Adverse Reactions
Learn About The Adverse Reactions
Of This Daily Asthma Treatment.
- Samples & Savings
Request Samples For Your Practice
Daily Triple Therapy Asthma Option.
- Formulary Coverage
See If Your Patients Are Covered
With This Daily Asthma Treatment.
- View Patient Profiles
Read More About Patient Profiles
On The HCP Website.
- Important Safety Info
Read About Safety & Side Effects
For An Asthma Triple Therapy.
- Dosing Information
Search results
Results From The WOW.Com Content Network
An inhaler (puffer, asthma pump or allergy spray) is a medical device used for delivering medicines into the lungs through the work of a person's breathing. This allows medicines to be delivered to and absorbed in the lungs, which provides the ability for targeted medical treatment to this specific region of the body, as well as a reduction in the side effects of oral medications.
Fluticasone furoate/vilanterol, sold under the brand name Breo Ellipta among others, is a combination medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. [3] It contains fluticasone furoate, an inhaled corticosteroid, and vilanterol, an ultra-long-acting β 2 agonist (ultra-LABA). [3]
Fluticasone furoate/umeclidinium bromide/vilanterol, sold under the brand name Trelegy Ellipta among others, is a fixed-dose combination inhaled medication that is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). [6] [7] The medications work in different ways: fluticasone furoate is an inhaled corticosteroid ...
This second medication in this combination is the synthetic inhaled corticosteroid fluticasone furoate. This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta.
The cost cap would apply to all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, including Advair Diskus, Advair HFA, and Trelegy Ellipta, and would apply to patients ...
It is estimated that four people with asthma and 85 people with COPD die in the UK every day. Dr Samantha Walker, from the charity Asthma + Lung UK, said the results were "great news".
Ads
related to: inhalers for copd and asthma